The Kaohsiung Journal of Medical Sciences
11 papers10 directions
The Kaohsiung Journal of Medical Sciences is a peer-reviewed publication that covers a broad range of topics within the medical and biological sciences. Active from 2003 through 2023, the journal serves as a venue for research concerning disease mechanisms, diagnostics, and therapeutic interventions. Its content primarily focuses on molecular biology, oncology, and genetics, providing a repository for studies that examine the complex interactions between genes, proteins, and signaling pathways in various pathologies.
The research published in this venue frequently involves the identification of biomarkers and the exploration of epigenetic regulations, such as histone methylation and the roles of long noncoding RNAs. Specific studies have investigated the HUWE1/ROCK2 axis in glioma cells, the impact of microRNAs on breast and gastric cancers, and the regulation of vascular endothelial cells. These contributions are relevant to the computational and machine learning communities as they provide the experimental data and biological frameworks necessary for developing predictive models and bioinformatics tools in precision medicine.
The journal features contributions from researchers such as Caiqin Mo, Kunlin Wu, and Ling Chen, among others. By documenting advancements in the understanding of cellular proliferation, migration, and metastasis, the venue supports the integration of clinical observations with molecular data. This role is essential for the ongoing development of data-driven approaches to medical research, where experimental findings inform the algorithmic analysis of disease progression and treatment response.
Papers by Year
| 2023 | 2 |
| 2022 | 5 |
| 2019 | 1 |
| 2016 | 1 |
| 2007 | 1 |
| 2003 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Impactful Papers
Papers from this venue that shaped research clusters.
Influential
<scp>ZNF521</scp>/<scp>EBF1</scp> axis regulates <scp>AKR1B1</scp> to promote the proliferation, mig
influential
Generalizability of In Vitro Findings to
2022